市場調查報告書
商品編碼
1384300
質子治療系統市場 - 按設定類型(單室、多室)、按適應症(乳腺癌、肺癌、前列腺癌、胃腸癌、腦癌)、按最終用途(醫院、質子治療中心) - 2032 年全球預測Proton Therapy Systems Market - By Set-up Type (Single Room, Multiple Room), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Gastro-intestinal Cancer, Brain Cancer), By End-use (Hospitals, Proton Therapy Centers) - Global Forecast to 2032 |
由於技術進步導致結果改善,質子治療系統市場規模預計 2023 年至 2032 年CAGR將超過 10.5%。例如,筆形束掃描和調強質子治療提高了治療精度並擴大了可治療病症的範圍。 2023 年 10 月,Mevion Medical Systems 在美國和加拿大推出了“Mevion Capital”,這是一種用於癌症放射治療的緊湊型質子治療系統。
此外,由於輻射引起的併發症風險較低,並且對健康組織的損害最小,因此質子治療成為兒童和成人患者的首選。這導致全球對質子治療系統的採用和需求增加。癌症患者群體的擴大和支持性報銷政策進一步影響了市場的成長軌跡。
整個質子治療系統市場根據設定類型、適應症、最終用途和地區進行分類。
預計到 2032 年,多房間設置類型細分市場將出現大幅成長,因為它們能夠有效地治療更多患者、減少等待時間並提供更好的醫療保健體驗。此類設施配備了多個治療室,使醫療保健提供者能夠滿足更多患者的需求。隨著醫療機構持續投資擴大質子治療能力,產品需求將會增加。
質子治療中心最終用途部分預計到 2032 年將產生大量收入,因為這些專用中心為患者提供全面的質子治療服務,確保最高品質的護理。質子治療中心在對抗癌症方面發揮著至關重要的作用,而且其數量正在增加。他們提供一系列的治療選擇,並且通常配備最先進的技術,使他們成為市場擴張的關鍵貢獻者。
由於中國、日本和韓國等國家癌症發病率的不斷上升、醫療基礎設施的發展以及醫療支出的增加,亞太地區質子治療系統市場將在 2023 年至 2032 年錄得強勁的CAGR。為了加強癌症治療選擇,亞太地區質子治療中心的建立激增。這些中心配備了最新的質子治療系統,方便該地區的人們獲得先進的癌症治療。
Proton therapy system market size is expected to record more than 10.5% CAGR from 2023 to 2032 due to the technological advancements that lead to improved results. For instance, pencil beam scanning and intensity-modulated proton therapy have enhanced treatment precision and expanded the range of treatable conditions. In October 2023, Mevion Medical Systems launched 'Mevion Capital' in US and Canada, a compact proton therapy system for use in radiation therapy of cancer.
Furthermore, the lower risk of radiation-induced complications and minimal damage to healthy tissues make proton therapy a preferred choice for both pediatric and adult patients. This has led to increased adoption and demand for proton therapy systems worldwide. The expanding pool of cancer patients and supportive reimbursement policies further influence the market growth trajectory.
The overall proton therapy systems market is divided based on set-up type, indication, end-use, and region.
The multiple room set-up type segment is predicted to witness substantial growth through 2032 due to their ability to treat more patients efficiently, reducing waiting times and providing a better healthcare experience. Such facilities are equipped with multiple treatment rooms and enable healthcare providers to cater to a larger patient population. As healthcare facilities continue to invest in expanding their proton therapy capabilities, the product demand will increase.
The proton therapy center end-use segment is anticipated to generate massive revenues by 2032 as these dedicated centers offer comprehensive proton therapy services to patients, ensuring the highest quality of care. Proton therapy centers are playing a crucial role in the fight against cancer, and their numbers are on the rise. They offer a range of treatment options and are often equipped with state-of-the-art technology, making them a key contributor to the market expansion.
Asia Pacific proton therapy systems market will record strong CAGR from 2023 to 2032 attributed to the growing prevalence of cancer, increasing healthcare infrastructure development, and rising medical expenditure in countries such as China, Japan, and South Korea. With a focus on enhancing cancer treatment options, the APAC region is witnessing a surge in the establishment of proton therapy centers. These centers are equipped with the latest proton therapy systems, facilitating access to advanced cancer treatments for the population in the region.